Improving Biopsies using Magnetic Nanoparticles
使用磁性纳米颗粒改善活检
基本信息
- 批准号:7477619
- 负责人:
- 金额:$ 33.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-07-20 至 2011-03-31
- 项目状态:已结题
- 来源:
- 关键词:Acute Lymphocytic LeukemiaAcute Promyelocytic LeukemiaAdjuvant TherapyAdoptedAntibodiesAntineoplastic AgentsApplications GrantsAreaAspirate substanceBindingBiochemicalBiocompatibleBiologicalBiological MarkersBiopsyBlood TestsBlood VesselsBlood specimenBone MarrowBone Marrow InvolvementBone marrow biopsyBreastCancerousCellsCharacteristicsChildChronic Myeloid LeukemiaClinicalClinical TrialsCollecting CellCollectionConditionCytometryDataDetectionDevelopmentDiseaseDrug usageDysmyelopoietic SyndromesEuropeExcisionFutureGoalsHeatingHodgkin DiseaseHumanHuman bodyLabelLeadLeftLifeLymphomaMagnetismMalignant NeoplasmsMarrowMeasurementMeasuresMetalsMethodologyMethodsMicroscopicMolecular ProfilingMonitorNanostructuresNanotechnologyNatureNeedle biopsy procedureNeedlesNumbersOvarianPainPatient MonitoringPatientsPersonal SatisfactionPhasePlasticsProceduresProcessPropertyProstatePublic HealthRandomizedRangeReportingResearch Ethics CommitteesResidual NeoplasmResidual TumorsSamplingSensitivity and SpecificitySiteSpecificitySquidStagingStandards of Weights and MeasuresT-Cell LeukemiaTechniquesTestingTherapeuticTherapeutic AgentsTherapeutic InterventionTimeTissuesWomanangiogenesisbasebcr-abl Fusion Proteinsbonecancer cellcancer sitecancer typecell typechemotherapyclinical applicationcontrolled releasedesignexperiencehyperthermia treatmentimprovedleukemiamagnetic fieldmalignant breast neoplasmmillisecondmovienanoparticlenanosystemsnovelolder patientoutcome forecastparticleperipheral bloodprognosticprogramsradius bone structuresensorsizetool
项目摘要
DESCRIPTION (provided by applicant): In children with acute lymphomatic leukemia (ALL) and in myelodysplastic syndrome (MDS) with older patients it is extremely important to measure the minimal residual disease (MRD) to monitor the progress of chemotherapy at early stages Such measurements determine the prognosis, efficacy, and levels of the treatment. The normal method for detection and monitoring is through bone marrow biopsies. Unfortunately, this method requires multiple biopsies to obtain sufficient samples and these must be made at periodic intervals to monitor the treatment. It is possible to substantially improve the efficiency of biopsies through the use of appropriately labeled magnetic nanoparticles and using magnetic collection methods. These antibody-labeled magnetic nanoparticles seek out, and attach themselves to, cancer cells, which can then be collected magnetically. This grant application describes the methodology behind this biopsy technique using a }smart} magnetic biopsy needle making it possible to substantially increase the efficiency of the biopsy as well as the specificity for particular leukemia cancer types but also including the sampling of metastatic rare cancer cells in the marrow. By using magnetic nanoparticles coated with anti-cancer agents and magnetically concentrated, direct therapeutic intervention at the cancer site is possible. PUBLIC HEALTH RELEVANCE: Nanotechnology for Disease Detection, Magnetic Nanoparticles for targeting Disease, Magnetic Needle for Bone Marrow Biopsy
描述(由申请人提供):在患有急性淋巴白血病(全部)的儿童中以及与老年患者的骨髓塑性综合征(MDS)中,测量最小的残留疾病(MRD)非常重要,以监测早期阶段化学疗法的进展,例如早期的测量结果决定了治疗的预后,疗效和治疗水平。检测和监测的正常方法是通过骨髓活检。不幸的是,此方法需要多个活检才能获得足够的样本,必须定期进行这些样本以监测治疗。通过使用适当标记的磁性纳米颗粒并使用磁收集方法,可以实质上提高活检的效率。这些抗体标记的磁性纳米颗粒会寻找并将其固定在癌细胞上,然后可以磁性地收集。该赠款应用使用A} smart}磁性活检针头描述了这种活检技术背后的方法,从而可以实质上提高活检的效率以及特定白血病癌症类型的特异性,但还包括对骨髓中转移性稀有癌细胞的取样。通过使用覆盖有抗癌药物的磁性纳米颗粒并磁浓缩,可以在癌症部位进行直接治疗干预。公共卫生相关性:用于疾病检测的纳米技术,用于靶向疾病的磁性纳米颗粒,用于骨髓活检的磁针
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EDWARD R FLYNN其他文献
EDWARD R FLYNN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EDWARD R FLYNN', 18)}}的其他基金
Fast-Track:Biomagnetic In-vivo Imaging of Ovarian Cancer
快速通道:卵巢癌生物磁体内成像
- 批准号:
7780637 - 财政年份:2008
- 资助金额:
$ 33.47万 - 项目类别:
Fast-Track:Biomagnetic In-vivo Imaging of Ovarian Cancer
快速通道:卵巢癌生物磁体内成像
- 批准号:
7386095 - 财政年份:2008
- 资助金额:
$ 33.47万 - 项目类别:
Biomagnetic Determinantion of Transplant Rejection
移植排斥的生物磁测定
- 批准号:
6989919 - 财政年份:2005
- 资助金额:
$ 33.47万 - 项目类别:
相似国自然基金
白血病细胞源性CCL3促进调节性T细胞迁移的机制及其在急性髓系白血病诊疗中的临床价值
- 批准号:
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:
Yap/Taz介导的髓源性抑制细胞(MDSC)生成在急性髓系白血病监测中的临床和机制研究
- 批准号:81802097
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Network-Based Novel Therapeutics in Colorectal Cancers
基于网络的结直肠癌新疗法
- 批准号:
9814960 - 财政年份:2019
- 资助金额:
$ 33.47万 - 项目类别:
Network-Based Novel Therapeutics in Colorectal Cancers
基于网络的结直肠癌新疗法
- 批准号:
10016858 - 财政年份:2019
- 资助金额:
$ 33.47万 - 项目类别:
Network-Based Novel Therapeutics in Colorectal Cancers
基于网络的结直肠癌新疗法
- 批准号:
10241395 - 财政年份:2019
- 资助金额:
$ 33.47万 - 项目类别:
Regulation of Mutant P53 Expression and Oncogenic Activity
突变 P53 表达和致癌活性的调节
- 批准号:
8676449 - 财政年份:2007
- 资助金额:
$ 33.47万 - 项目类别:
Regulation of Mutant P53 Expression and Oncogenic Activity
突变 P53 表达和致癌活性的调节
- 批准号:
8520202 - 财政年份:2007
- 资助金额:
$ 33.47万 - 项目类别: